Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasmsKelly S. Chien, Guillermo Garcia‐Manero, Sherry Pierce et al.|Cancer Medicine|2024Cited by 11
Outcomes of hypomethylating agent failure in patients with myelodysplastic syndromesKelly S. Chien, Guillermo Garcia-Manero, Ziyi Li et al.|Blood|2025Cited by 1
Genomic Evolution of Patients with Myelodysplastic Syndrome after Hypomethylating Agent FailureKelly S. Chien, Guillermo Garcia‐Manero, Kunhwa Kim et al.|Blood|2022Cited by 0
Outcomes of individuals with clonal hematopoiesis evaluated at a cancer center.Kelly S. Chien, Guillermo Garcia‐Manero, Faustine Ong et al.|Journal of Clinical Oncology|2023Cited by 0
PB2481: OUTCOMES OF INDIVIDUALS WITH CLONAL HEMATOPOIESIS EVALUATED AT A CANCER CENTERKelly S. Chien, Guillermo Garcia‐Manero, Faustine Ong et al.|HemaSphere|2023Cited by 0